Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). (Q37569035)
Jump to navigation
Jump to search
scientific article published on August 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). |
scientific article published on August 2008 |
Statements
1 reference
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). (English)
1 reference
Aminah Jatoi
1 reference
Kendrith Rowland
1 reference
Jeff A Sloan
1 reference
Howard M Gross
1 reference
Paul A Fishkin
1 reference
Stephen P Kahanic
1 reference
Paul J Novotny
1 reference
Paul L Schaefer
1 reference
David B Johnson
1 reference
Loren K Tschetter
1 reference
Charles L Loprinzi
1 reference
1 August 2008
1 reference
1 reference
847-853
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference